We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Serum biomarker patterns can distinguish prednisone from vamorolone and may explain treatment-related growth complications in DMD. More...
08 Sep 2026
Image: The FDA‑cleared NanoZoomer lineup now spans compact benchtop deployment with the S20MD, routine laboratory workflows with the S360MD, and high‑throughput laboratory operations with the S540MD (Photo courtesy of Hamamatsu Photonics K.K.)

FDA-Cleared Slide Scanners Expand Digital Pathology from Benchtop to High-Throughput

A new pair of FDA-cleared slide scanners enables scalable digital pathology from benchtop to high-throughput clinical labs. More...
08 Sep 2026
Image: Low magnification micrograph of mantle cell lymphoma of the terminal ileum (Image Credit: Nephron/Wikimedia Commons, CC BY-SA 3.0)

Biomarker-Guided Framework Aims to Guide Mantle Cell Lymphoma Therapy

A risk-adapted framework uses diagnostic markers to tailor MCL therapy and guide MRD-informed management. More...
07 Sep 2026
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

WHO granted Emergency Use Listing (EUL) for Cepheid's Xpert Hemorrhagic Fever Panel to support diagnostics during the Ebola Bundibugyo outbreak. More...
07 Sep 2026
Image: The latest FDA approval expands the Guardant360 CDx platform to 29 companion diagnostic indications globally (Photo courtesy of Guardant Health)

FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch

Guardant360 CDx was FDA-approved to identify ESR1 mutations and guide camizestrant use in HR+/HER2- breast cancer. More...
07 Sep 2026
Image Credit: Adobe Stock

New Gene-Disease Link May Help Diagnose Rare Neurodevelopmental Disorders

New data identify gene variants linked to a neurodevelopmental disorder, enabling faster diagnosis and variant interpretation. More...
07 Sep 2026
Image: The latest FDA approval expands the Guardant360 CDx platform to 29 companion diagnostic indications globally (Photo courtesy of Guardant Health)

FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch

Guardant360 CDx was FDA-approved to identify ESR1 mutations and guide camizestrant use in HR+/HER2- breast cancer. More...
05 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Portable POCT Blood Gas Analyzer
BD100
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Copyright © 2000-2026 Globetech Media. All rights reserved.